Our Research Publications
Updated August 2025
Pagination
- Previous page
- Page 24
- Next page
Title | Authors | Year Sort ascending | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Epidemiology of Hospitalized Patients with Babesiosis, United States, 2010-2016 | Bloch EM, Day JR, Krause PJ, Kjemtrup A, O'Brien SF, Tobian AAR, Goel R | 2022 | Emerg Infect Dis | View Epidemiology of Hospitalized Patients with Babesiosis, United States, 2010-2016 | Health care providers | Clinical research |
Bacterial contamination of blood components | Bloch EM, Benjamin RJ, Ramirez-Arcos S | 2022 | Rossi's Principles of Transfusion Medicine | View Bacterial contamination of blood components | Health care providers | Benchmarking and standard setting |
Closed system processing variables affect post-thaw quality characteristics of cryopreserved red cell concentrates | Howell A, Turner TR, Hansen A, Lautner LJ, Yi Q, Acker JP | 2022 | Transfusion | View Closed system processing variables affect post-thaw quality characteristics of cryopreserved red cell concentrates | Researchers | Basic research |
Development and validation of a sensitive flow cytometric method for determining CECs in RBC products | Li W, Acker JP | 2022 | Clin Chim Acta | View Development and validation of a sensitive flow cytometric method for determining CECs in RBC products | Researchers | New or improved product or process |
Canadian blood suppliers: An expanding role in public health surveillance? | O'Brien SF, Drews SJ, Lewin A, Osiowy C, Drebot MA, Renaud C | 2022 | Can Commun Dis Rep | View Canadian blood suppliers: An expanding role in public health surveillance? | Health care providers | New or improved product or process |
Minimal impact of anticoagulant on in vitro whole blood quality throughout a 35-day cold-storage regardless of leukoreduction timing | Schubert P, Culibrk B, Bhakta V, Closas T, Sheffield WP, Devine DV, McTaggart K | 2022 | Transfusion | View Minimal impact of anticoagulant on in vitro whole blood quality throughout a 35-day cold-storage regardless of leukoreduction timing | Researchers | Basic research |
Novel contact–kinin inhibitor sylvestin targets thromboinflammation and ameliorates ischemic stroke | Zhang Z, Shen C, Fang M, Han Y, Long C, Liu W, Yang M, Liu M, Zhang D, Cao Q, Chen X, Fang Y, Lu Q, Hou Z, Li Y, Liu Z, Lei X, Ni H, Lai R | 2022 | Cell Mol Life Sci | View Novel contact–kinin inhibitor sylvestin targets thromboinflammation and ameliorates ischemic stroke | Researchers | Basic research |
Effect of modern infusion pumps on RBC quality | Hadjesfandiari N, Serrano K, Levin E, Johal P, Feenstra S, Shih AW, Devine DV | 2022 | Transfusion | View Effect of modern infusion pumps on RBC quality | Researchers | Benchmarking and standard setting |
International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemic | Al-Riyami AZ, Burnouf T, Wood EM, Devine DV, Oreh A, Apelseth TO, Goel R, Bloch EM, van Den Berg K, Getshen M, Louw V, Ang AL, Lee CK, Rahimi-Levene N, Stramer SL, Vassallo R, Schulze TJ, Patidar GK, Pandey HC, Dubey R, Badawi M, Hindawi S, Meshi A, Matsushita T, Sorrentino E, Grubovic Rastvorceva RM, Bazin R, Vermeulen M, Nahirniak S, Tsang HC, Vrielink H, Triyono T, Addas-Carvalho M, He?imovi? A, Torres OW, Mutindu SM, Bengtsson J, Dominguez D, Sayedahmed A, Hanisa Musa R, Gautam B, Herczenik E, So-Osman C, the ISBT COVID-19 Convalescent Plasma Working Group | 2022 | Vox Sang | View International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemic | Health care providers | Benchmarking and standard setting |
The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia | Bissola AL, Daka M, Arnold DM, Smith JW, Moore JC, Clare R, Ivetic N, Kelton JG, Nazy I | 2022 | Blood Adv | View The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia | Researchers | Clinical research |
Transfusion-Transmitted Infections | Drews SJ, Dodd RY | 2022 | Practical Transfusion Medicine | View Transfusion-Transmitted Infections | Health care providers | Benchmarking and standard setting |
Understanding the experiences of plasma donors in Canada's new source plasma collection centres during COVID-19: A qualitative study | Holloway K | 2022 | Vox Sang | View Understanding the experiences of plasma donors in Canada's new source plasma collection centres during COVID-19: A qualitative study | Researchers | Ethical, legal & social implications research |
c-Mpl-del, a c-Mpl alternative splicing isoform, promotes AMKL progression and chemoresistance | Li F, Xiong Y, Yang M, Chen P, Zhang J, Wang Q, Xu M, Wang Y, He Z, Zhao X, Huang J, Gu X, Zhang L, Sun R, Sun X, Li J, Ou J, Xu T, Huang X, Cao Y, Xu XR, Karakas D, Li J, Ni H, Zhang Q | 2022 | Cell Death Dis | View c-Mpl-del, a c-Mpl alternative splicing isoform, promotes AMKL progression and chemoresistance | Researchers | Basic research |
Switching from standard to extended half-life FVIII prophylaxis in haemophilia A: Comparison of factor product use, bleed rates and pharmacokinetics | Nummi V, Lehtinen AE, Iorio A, Szanto T, Lassila R | 2022 | Haemophilia | View Switching from standard to extended half-life FVIII prophylaxis in haemophilia A: Comparison of factor product use, bleed rates and pharmacokinetics | Researchers | Clinical research |
Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era | Reedman CN, Drews SJ, Yi Q-L, Pambrun C, O’Brien SF | 2022 | Microbiol Spectr | View Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era | Researchers | Clinical research |
Bacterial contamination of platelet components | Ramirez-Arcos S, McDonald C, ISBT Transfusion-Transmitted Infectious Disease Bacterial Working Party Bacterial Subgroup | 2022 | Ann Blood | View Bacterial contamination of platelet components | Blood operators | Benchmarking and standard setting |
Behaviour based screening questions and potential donation loss using the “for the assessment of individualised risk” screening criteria: A Canadian perspective | Caffrey N, Goldman M, Lewin A, Osmond L, O'Brien SF | 2022 | Transfus Med | View Behaviour based screening questions and potential donation loss using the “for the assessment of individualised risk” screening criteria: A Canadian perspective | Researchers | MSM research |
Screening for high-risk sexual behavior in Canada | Goldman M, Caffrey N, O'Brien SF | 2022 | Transfusion | View Screening for high-risk sexual behavior in Canada | Blood operators | Clinical research |
FAQ: Whole blood, leukocytes reduced (LrWB) at Canadian Blood Services | Mack J | 2022 | Blood.ca website | View FAQ: Whole blood, leukocytes reduced (LrWB) at Canadian Blood Services | Health care providers | New or improved product or process |
Circulaire d'information utilisation de composants sanguins humains: Cellules progénitrices hématopiétiques de sang de cordon omilical | Stewart T | 2022 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Cellules progénitrices hématopiétiques de sang de cordon omilical | Health care providers | Benchmarking and standard setting |
Lessons learned in the collection of convalescent plasma during the COVID-19 pandemic | Wendel S, Land K, Devine DV, Daly J, Bazin R, Tiberghien P, Lee C-K, Arora S, Patidar GK, Khillan K, Smid WM, Vrielink H, Oreh A, Al-Riyami AZ, Hindawi S, Vermeulen M, Louw V, Burnouf T, Bloch EM, Goel R, Townsend M, So-Osman C | 2021 | Vox Sang | View Lessons learned in the collection of convalescent plasma during the COVID-19 pandemic | Blood operators | New or improved product or process |
Chapter 11: Massive hemorrhage and emergency transfusion | Trudeau J, Dawe P, Shih A | 2021 | Clinical Guide to Transfusion | View Chapter 11: Massive hemorrhage and emergency transfusion | Health care providers | Benchmarking and standard setting |
Current challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence studies among blood donors: A scoping review | Saeed S, Uzicanin S, Lewin A, Lieshout-Krikke R, Faddy H, Erikstrup C, Osiowy C, Seed C, Steele W, Davidson K, Custer B, O’Brien S, Assessment ObotSR, Policy sub-group of the Transfusion Transmitted Infectious Diseases Working Party of the International Society of Blood Transfusion | 2021 | medRxiv | View Current challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence studies among blood donors: A scoping review | Researchers | Basic research |
International Forum on Walking Blood Bank Programmes: Summary | Martinaud C, Scorer T, Lozano M, Miles A, Fitchett G, Ba A, Wikman A, Nimberger-Hansson P, Enbuske S, Bohon?k M, Devine D, Beckett AN, Mbanya D, T'Sas F, Degueldre J, Chueca M, Dedome E, Apelseth T, Strandenes G, Wendel S, Fachini R, Olszewski A, Dupont C, Glassberg E, Shinar E, Taylor AL, Corley JB, Sekaran Nadarajan V, Dunbar N | 2021 | Vox Sang | View International Forum on Walking Blood Bank Programmes: Summary | Blood operators | Benchmarking and standard setting |
CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models | Kapopara PR, Safikhan NS, Huang JL, Meixner SC, Gonzalez K, Loghmani H, Ruf W, Mast AE, Lei V, Pryzdial ELG, Conway EM | 2021 | J Thromb Haemost | View CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models | Researchers | Basic research |
Rethinking platelet transfusion practices | Devine DV | 2021 | Blood | View Rethinking platelet transfusion practices | Health care providers | New or improved product or process |
Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): Study protocol for an international, multicenter, randomized open-label trial | Bégin P, Callum J, Heddle N, Cook R, Zeller MP, Tinmouth A, Fergusson D, Cushing MM, Glesby MJ, Chassé M, Devine DV, Robitaille N, Bazin R, Shehata N, Finzi A, McGeer A, Scales D, Schwartz L, Turgeon AF, Zarychanski R, Daneman N, Carl R, Amorim L, Gabe C, Ellis M, Jamula E, Carruthers J, Duncan J, Lucier K, Armali C, Kron A, Modi D, Auclair M-C, Avram M, Arnold DM | 2021 | Trials | View Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): Study protocol for an international, multicenter, randomized open-label trial | Researchers | Clinical research |
Convalescent plasma for hospitalized patients with COVID-19 and the effect of plasma antibodies: a randomized controlled, open-label trial | Bégin P, Callum J, Jamula E, Cook R, Heddle NM, Tinmouth A, Zeller MP, Beaudoin-Bussières G, Amorim L, Bazin R, Loftsgard KC, Carl R, Chassé M, Cushing MM, Daneman N, Devine DV, Dumaresq J, Fergusson DA, Gabe C, Glesby MJ, Li N, Liu Y, McGeer A, Robitaille N, Sachais BS, Scales DC, Schwartz L, Shehata N, Turgeon AF, Wood H, Zarychanski R, Finzi A, Arnold DM, for The CONCOR-1 Study Group | 2021 | medRxiv | View Convalescent plasma for hospitalized patients with COVID-19 and the effect of plasma antibodies: a randomized controlled, open-label trial | Health care providers | Clinical research |
In Vitro Characterization and Metabolomic Analysis of Cold-Stored Platelets | Zhao HW, Serrano K, Stefanoni D, D’Alessandro A, Devine DV | 2021 | J Proteome Res | View In Vitro Characterization and Metabolomic Analysis of Cold-Stored Platelets | Researchers | Basic research |
Pathogen reduction of whole blood: Supplementing fibrinogen partly corrects clot formation in a massive transfusion model | Arbaeen AF, Schubert P, Sheffield WP, Devine DV | 2021 | Transfusion | View Pathogen reduction of whole blood: Supplementing fibrinogen partly corrects clot formation in a massive transfusion model | Researchers | New or improved product or process |
ResearchUnit: Perioperative treatment for patients with immune thrombocytopenia: Eltrombopag vs IVIG | Arnold DM | 2021 | Blood.ca website | View ResearchUnit: Perioperative treatment for patients with immune thrombocytopenia: Eltrombopag vs IVIG | Health care providers | Clinical research |
Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: Fraternal-Not Identical-Twins | Warkentin TE | 2021 | Thromb Haemost | View Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: Fraternal-Not Identical-Twins | Researchers | Clinical research |
Vaccine-induced immune thrombotic thrombocytopenia presenting with normal platelet count | Page D, Zhu N, Sawler D, Sun HW, Turley E, Pai M, Wu C | 2021 | Res Pract Thromb Haemost | View Vaccine-induced immune thrombotic thrombocytopenia presenting with normal platelet count | Researchers | Clinical research |
Teaching bone marrow procedures at pelvic and sternal sites: a high fidelity anatomy simulation | Heather Vander M, Laureano M, Hu G, Lim W, Ross C, Wainman B, Zeller MP | 2021 | Can Med Educ J | View Teaching bone marrow procedures at pelvic and sternal sites: a high fidelity anatomy simulation | Health care providers | Benchmarking and standard setting |
Chaptire 16: Don autologue préopératoire | Foster T, Yan M | 2021 | Guide de la pratique transfusionnelle | View Chaptire 16: Don autologue préopératoire | Health care providers | Benchmarking and standard setting |
External qualification of the Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) models for octocog alfa using real patient data | Chelle P, Hajducek D, Mahdi M, Young S, Iorio A, Silvertown J, Edginton A | 2021 | Res Pract Thromb Haemost | View External qualification of the Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) models for octocog alfa using real patient data | Researchers | New or improved product or process |
Necrotizing enterocolitis and mortality after transfusion of ABO non-identical blood | Parvizian MK, Barty R, Heddle NM, Li N, McDougall T, Mukerji A, Fusch C, Solh Z | 2021 | Transfusion | View Necrotizing enterocolitis and mortality after transfusion of ABO non-identical blood | Researchers | Clinical research |
Mechanism of increased efficacy of recombinant Fc-?TP-L309C compared to IVIg to ameliorate mouse immune thrombocytopenia | Lewis BJB, Binnington B, Blacquiere M, Spirig R, Käsermann F, Branch DR | 2021 | eJHaem | View Mechanism of increased efficacy of recombinant Fc-?TP-L309C compared to IVIg to ameliorate mouse immune thrombocytopenia | Researchers | Basic research |
Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fc? receptor inhibition | Norris PAA, Kaur G, Khan R, Zhu G, Ni H, Lazarus AH | 2021 | Blood | View Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fc? receptor inhibition | Researchers | Basic research |
Evidence of SARS-CoV-2 Infection in Cells, Tissues, and Organs and the Risk of Transmission Through Transplantation | Gaussen A, Hornby L, Rockl G, O’Brien S, Delage G, Sapir-Pichhadze R, Drews SJ, Weiss MJ, Lewin A | 2021 | Transplantation | View Evidence of SARS-CoV-2 Infection in Cells, Tissues, and Organs and the Risk of Transmission Through Transplantation | Health care providers | Clinical research |
Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC), Cord Blood | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
The SSC platelet immunology register of VITT and VIITP: Toward standardization of laboratory and clinical parameters | Choi PY, Grace RF, Therese Ahlen M, Nazy I, Sachs UJ, Arnold DM, McKenzie SE, Althaus K, Sharma R, Bakchoul T | 2021 | J Thromb Haemost | View The SSC platelet immunology register of VITT and VIITP: Toward standardization of laboratory and clinical parameters | Researchers | Benchmarking and standard setting |
ResearchUnit: Intravenous albumin is not associated with improved outcomes in cardiac surgery patients | Bartoszko J | 2021 | Blood.ca website | View ResearchUnit: Intravenous albumin is not associated with improved outcomes in cardiac surgery patients | Health care providers | Clinical research |
FAQ: Canadian Blood Services Platelet Bacterial Testing | Khandelwal A, Ramirez-Arcos S, Bigham M | 2021 | Blood.ca website | View FAQ: Canadian Blood Services Platelet Bacterial Testing | Health care providers | Other |
Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia | Nazy I, Jevtic SD, Moore JC, Huynh A, Smith JW, Kelton JG, Arnold DM | 2021 | J Thromb Haemost | View Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia | Health care providers | Clinical research |
Selection and in vitro and in vivo characterization of a Kunitz protease inhibitor domain of protease nexin 2 variant that inhibits factor XIa without inhibiting plasmin | Eltringham-Smith LJ, Bhakta V, Sheffield WP | 2021 | J Biotechnol | View Selection and in vitro and in vivo characterization of a Kunitz protease inhibitor domain of protease nexin 2 variant that inhibits factor XIa without inhibiting plasmin | Researchers | Basic research |
Five novel FY null alleles associated with typing discrepancies | Vege S, Floch A, Lomas-Frances C, Clarke G, Westhoff CM | 2021 | Transfusion | View Five novel FY null alleles associated with typing discrepancies | Researchers | Benchmarking and standard setting |
Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study | Nasreen S, Calzavara AJ, Sundaram ME, MacDonald SE, Righolt CH, Pai M, Field TS, Zhou LW, Wilson SE, Kwong JC | 2021 | BMJ Open | View Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study | Researchers | Clinical research |
Plateletworks® as a Point-of-Care Test for ASA Non-Sensitivity | Khan H, Jain S, Gallant RC, Syed MH, Zamzam A, Al-Omran M, Rand ML, Ni H, Abdin R, Qadura M | 2021 | J Pers Med | View Plateletworks® as a Point-of-Care Test for ASA Non-Sensitivity | Researchers | New or improved product or process |
Chapter 2: Blood components | Gupta A, Bigham M | 2021 | Clinical Guide to Transfusion | View Chapter 2: Blood components | Health care providers | Benchmarking and standard setting |